DR. JEREMY SCOTT MCDUFFIE M.D. NPI 1811158942

NPI Information

  • NPI: 1811158942
  • Provider Name: DR. JEREMY SCOTT MCDUFFIE, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1840 MEDICAL CENTER PKWY
    SUITE 300
    MURFREESBORO, TN
    ZIP 37129
  • Phone: (615) 848-0488

Map and Directions

Get Directions

NPI Details

DR. Jeremy Scott Mcduffie, M.D. is a hematology and oncology internal medicine in Murfreesboro, TN with 17 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Jeremy Scott Mcduffie, M.D. NPI is 1811158942. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MEHARRY MEDICAL COLLEGE SCHOOL OF MEDICINE
Graduation Year:2008

The provider's business location address is:

1840 MEDICAL CENTER PKWY
SUITE 300
MURFREESBORO, TN
ZIP 37129-199
Phone: (615) 848-0488
Fax: (615) 904-9061

The NPI 1811158942 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Protein measurement, serum (HCPCS:84165)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Cortisol (hormone) measurement, total (HCPCS:82533)
  • Magnesium level (HCPCS:83735)
  • Blood test, clotting time (HCPCS:85610)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Erythropoietin (protein) level (HCPCS:82668)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Phosphate level (HCPCS:84100)
  • Uric acid level, blood (HCPCS:84550)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
  • Red blood count, automated test (HCPCS:85045)

The enumeration date for this NPI number is 6/20/2008 and was last updated on 10/2/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1174400000XSpecialist071827GEORGIANo
2207RH0003XInternal MedicineHematology & Oncology53413TENNESSEEYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
11811158942OTHERGEORGIANPI NUMBER

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.